Product Images Phenytoin Sodium

Phenytoin Sodium Injection is a medication administered intravenously or intramuscularly using a 2mL vial containing 100mg per 2mL, at a concentration of 50mg/mL. The lot number is 123456 and the expiration date is 2030-01-81. The NDC number is 51662-1251-2. The medication should not be used if it appears hazy or contains precipitate. Sodium hydroxide may be added for pH adjustment. One mL of the solution contains 50mg of phenytoin sodium, propylene glycol 4mL, and alcohol 1TmL in water for injection. The usual dosage and complete prescribing information can be found in the package insert provided by the manufacturer. The medication is to be stored within the temperature range of 20°C-25°C (68°F-77°F). The manufacturer is HFAcquisitionCo., LLC of Mukilteo, WA. This medication is available only by prescription.*

Phenytoin Sodium Injection is a medication that comes in a box of 25 vials. Each vial contains 100mg of the medication in 2mL of solution, with a concentration of 58mg/mL. The lot number is 123056 and the expiration date is January 1, 2050. The injection is intended for intravenous use and contains phenytoin sodium. The manufacturer's name is not readable due to error. This medication requires a prescription.*

Intravenous administration of Phenytoin Sodium Injection should be done with caution as it carries a risk of severe hypotension and cardiac arrhythmias. The recommended administration rate should not exceed 50 mg per minute in adults and 1 to 3 mg/kg/min in pediatric patients. Careful cardiac monitoring is necessary during and after the administration. Cardiovascular toxicity can occur even at or below the recommended infusion rate. It may require a reduction in the rate of administration or discontinuation of dosing.*

This is a list of drugs that may interact with phenytoin, an anti-seizure medication. Some drugs may increase phenytoin serum levels, including antiepileptic drugs, azoles, antineoplastic agents, antidepressants, gastric acid reducing agents, and sulfonamides. Other drugs, such as acute alcohol intake and warfarin, may also increase serum levels. Conversely, some drugs may decrease phenytoin serum levels, such as antineoplastic agents usually in combination, antiviral agents, and chronic alcohol abuse. Some antiepileptic drugs may either increase or decrease phenytoin serum levels.*

This text lists examples of drugs that may interact with phenytoin, which can impair their efficacy or decrease their levels in the body. Examples of drugs whose efficacy may be impaired by phenytoin include azoles, antineoplastic agents, neuromuscular blocking agents, and warfarin. Various drugs including carbamazepine, antilipidemic agents, antiviral agents, and calcium channel blockers may have their level decreased by phenytoin. Patients who are taking these drugs with phenytoin should be monitored closely for possible effects.*

Phenytoin Sodium Injection is a medication that should be administered intravenously with caution. Rapid infusion can lead to severe hypotension and cardiac arrhythmias. To avoid these risks, the rate of administration should not exceed 50 mg per minute in adults and 1 to 3 mg/kg/min (or 50 mg per minute, whichever is slower) in pediatric patients. Careful cardiac monitoring is necessary during and after administration of this medication. A reduction in the rate of administration or discontinuation of dosing may be necessary. A boxed warning is included in the full prescribing information for this medication due to the significant cardiovascular risk associated with rapid infusion.*

This is a prescription drug with the National Drug Code (NDC) 0641-0493-21. It is for intravenous or intramuscular use only and contains 50 mg/mt per 2 mL single-dose vial. The drug is not recommended to be used in hazE or as a precipitate. It is manufactured by Westward.*